| State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 |
173 |
| The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes |
40 |
| Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control |
28 |
| Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes |
25 |
| Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review |
22 |
| Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus |
17 |
| Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes |
16 |
| Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch |
16 |
| Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator |
15 |
| Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes |
15 |
| Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes |
15 |
| Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes |
14 |
| Preserving Skin Integrity with Chronic Device Use in Diabetes |
14 |
| The Hybrid Closed-Loop System: Evolution and Practical Applications |
14 |
| Adoption of New Glucose-Lowering Medications in the US-The Case of SGLT2 Inhibitors: Nationwide Cohort Study |
14 |
| Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes |
14 |
| Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting |
13 |
| Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study |
12 |
| Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity |
12 |
| The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis |
12 |
| Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial |
12 |
| Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems |
12 |
| A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II |
12 |
| The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set |
12 |
| Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes |
12 |
| The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 000 Consecutive Encounters from People with Diabetes |
12 |
| CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care |
11 |
| The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study |
11 |
| Flash Glucose Measurements in Children with Type 1 Diabetes in Real-Life Settings: To Trust or Not to Trust? |
11 |
| Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial |
11 |
| Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study |
11 |
| A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) |
11 |
| Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data |
10 |
| Glucose Variability: A Review of Clinical Applications and Research Developments |
10 |
| Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study |
10 |
| Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study |
9 |
| Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm |
9 |
| Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice |
9 |
| Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System |
9 |
| Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes |
9 |
| Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System |
9 |
| Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes |
9 |
| Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites |
9 |
| Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study |
9 |
| Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort |
9 |
| Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with Risk Indices |
9 |
| Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert |
9 |
| Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes |
8 |
| Safe Completion of a Trail Running Ultramarathon by Four Men with Type 1 Diabetes |
8 |
| Application of Machine Learning to Identify Clustering of Cardiometabolic Risk Factors in US Adults |
8 |
